Literature DB >> 22847127

Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.

Kenneth Cardona1, Pedro Mastrodomenico, Francesco D'Amico, Jinru Shia, Mithat Gönen, Martin R Weiser, Philip B Paty, T Peter Kingham, Peter J Allen, Ronald P De Matteo, Yuman Fong, William R Jarnagin, Michael I D'Angelica.   

Abstract

INTRODUCTION: Outcome after hepatic resection for colorectal cancer liver metastases (CRLM) is heterogeneous and accurate predictors of survival are lacking. This study analyzes the prognostic relevance of pathologic details of the primary colorectal tumor in patients undergoing hepatic resection for CRLM.
METHODS: Retrospective review of a prospective database identified patients who underwent resection for CRLM. Clinicopathological variables were investigated and their association with outcome was analyzed.
RESULTS: From 1997-2007, 1,004 patients underwent hepatic resection for CRLM. The median follow-up was 59 months with a 5-year survival of 47%. Univariate analysis identified nine factors associated with poor survival; three of these related to the primary tumor: lymphovascular invasion (LVI, p<0.0001), perineural invasion (p=0.005), and degree of regional lymph node involvement (N0 vs. N1 vs. N2, p<0.0001). Multivariate analysis identified seven factors associated with poor survival, two of which related to the primary tumor: LVI (hazard ratio (HR) 1.3, 95% confidence interval (CI) 1.06-1.64, p=0.01) and degree of regional lymph node involvement [N1 (HR 1.3, 95% CI 1.04-1.69, p=0.02) vs. N2 (HR 1.7, 95% CI 1.27-2.21, p<0.0005)]. A significant decrease in survival along the spectrum of patients ranging from LVI negative/N0 to LVI positive/N2 was present. Patients who were LVI-positive/N2 had a median survival of 40 months compared with 74 months for patients who were LVI-negative/NO (p<0.0001).
CONCLUSIONS: Histopathologic details of the primary colorectal tumor, particularly LVI and the detailed assessment of the degree of lymph node involvement, are strong predictors of survival. Future biomarker studies should consider exploring factors related to the primary colorectal tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22847127     DOI: 10.1245/s10434-012-2540-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.

Authors:  John M Creasy; Eran Sadot; Bas Groot Koerkamp; Joanne F Chou; Mithat Gonen; Nancy E Kemeny; Leonard B Saltz; Vinod P Balachandran; T Peter Kingham; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-11-27       Impact factor: 5.344

2.  Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a "liver first" approach protocol.

Authors:  Dimitrios Kardassis; Achilleas Ntinas; Dimosthenis Miliaras; Alexandros Kofokotsios; Konstantinos Papazisis; Dionisios Vrochides
Journal:  World J Hepatol       Date:  2014-07-27

3.  The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients.

Authors:  Lauren M Postlewait; Malcolm H Squires; David A Kooby; Sharon M Weber; Charles R Scoggins; Kenneth Cardona; Clifford S Cho; Robert C G Martin; Emily R Winslow; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2015-11-14       Impact factor: 3.647

Review 4.  A literature review of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): so far, so good.

Authors:  Martin de Santibañes; Luis Boccalatte; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2016-10-20

5.  Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer.

Authors:  Jieun Kang; Yun Hee Kang; Byung Moo Oh; Tae Gi Uhm; Sang Yoon Park; Tae Woo Kim; Seung Ro Han; Seon-Jin Lee; Younghee Lee; Hee Gu Lee
Journal:  Tumour Biol       Date:  2016-08-02

6.  A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.

Authors:  Caroline E Poorman; Cecilia G Ethun; Lauren M Postlewait; Thuy B Tran; Jason D Prescott; Timothy M Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solórzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Charles A Staley; George A Poultsides; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2017-11-21       Impact factor: 5.344

7.  Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.

Authors:  Alan A Thomay; David M Nagorney; Steven J Cohen; Elin R Sigurdson; Mark J Truty; Barbara Burtness; Michael J Hall; Yun Shin Chun
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

8.  PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Authors:  Renato Gomes Campanati; João Bernardo Sancio; Lucas Mauro de Andrade Sucena; Marcelo Dias Sanches; Vivian Resende
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

Review 9.  Surgery for colorectal liver metastases: The evolution of determining prognosis.

Authors:  Gaya Spolverato; Aslam Ejaz; Nilo Azad; Timothy M Pawlik
Journal:  World J Gastrointest Oncol       Date:  2013-12-15

10.  Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.

Authors:  Lauren M Postlewait; Cecilia G Ethun; Nina Le; Timothy M Pawlik; Stefan Buettner; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Gerardo Vitiello; Kenneth Cardona; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2016-08-09       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.